Recent News

• 09.12.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.12.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.12.2025 - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.04.2025 - Cantor Fitzgerald 2025 Annual Global Healthcare Conference
• 09.04.2025 - Cantor Fitzgerald 2025 Annual Global Healthcare Conference
• 08.26.2025 - Fulcrum Therapeutics to Present at Upcoming Investor Meetings
• 08.26.2025 - Fulcrum Therapeutics to Present at Upcoming Investor Meetings
• 08.26.2025 - Fulcrum Therapeutics to Present at Upcoming Investor Meetings

Recent Filings

• 08.28.2025 - 8-K Current report
• 08.28.2025 - EX-99.1 EX-99.1
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors